87,592 Shares in LivaNova PLC (LIVN) Purchased by Teachers Advisors LLC
Teachers Advisors LLC bought a new stake in LivaNova PLC (NASDAQ:LIVN) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 87,592 shares of the company’s stock, valued at approximately $5,362,000. Teachers Advisors LLC owned about 0.18% of LivaNova PLC as of its most recent SEC filing.
Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Airain ltd acquired a new stake in LivaNova PLC in the 2nd quarter valued at approximately $1,449,000. Virginia Retirement Systems ET AL acquired a new stake in LivaNova PLC in the 2nd quarter valued at approximately $2,277,000. Hosking Partners LLP grew its holdings in LivaNova PLC by 1.6% in the 2nd quarter. Hosking Partners LLP now owns 188,518 shares of the company’s stock valued at $11,539,000 after buying an additional 3,048 shares during the last quarter. Arizona State Retirement System grew its holdings in LivaNova PLC by 1.7% in the 2nd quarter. Arizona State Retirement System now owns 18,300 shares of the company’s stock valued at $1,120,000 after buying an additional 300 shares during the last quarter. Finally, Russell Investments Group Ltd. acquired a new stake in LivaNova PLC in the 2nd quarter valued at approximately $957,000. 82.25% of the stock is currently owned by hedge funds and other institutional investors.
A number of research firms have issued reports on LIVN. Canaccord Genuity reaffirmed a “hold” rating and issued a $71.00 target price on shares of LivaNova PLC in a report on Wednesday, September 20th. Jefferies Group LLC raised their target price on LivaNova PLC from $76.00 to $80.00 and gave the company a “buy” rating in a report on Friday, September 15th. Needham & Company LLC raised LivaNova PLC from a “hold” rating to a “buy” rating and set a $83.00 target price on the stock in a report on Friday, September 15th. Piper Jaffray Companies reaffirmed an “overweight” rating and issued a $75.00 target price on shares of LivaNova PLC in a report on Tuesday, September 12th. Finally, WBB Securities lowered LivaNova PLC from a “hold” rating to a “sell” rating and set a $50.00 target price on the stock. in a report on Tuesday, August 15th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and four have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average target price of $71.50.
Shares of LivaNova PLC (LIVN) opened at 75.29 on Wednesday. LivaNova PLC has a 12-month low of $40.83 and a 12-month high of $75.42. The firm has a market cap of $3.68 billion, a price-to-earnings ratio of 134.45 and a beta of 0.59. The firm has a 50-day moving average price of $67.23 and a 200-day moving average price of $60.30.
LivaNova PLC (NASDAQ:LIVN) last announced its quarterly earnings results on Wednesday, August 9th. The company reported $1.01 earnings per share for the quarter, topping analysts’ consensus estimates of $0.82 by $0.19. LivaNova PLC had a return on equity of 9.08% and a net margin of 2.26%. The firm had revenue of $321.40 million for the quarter, compared to the consensus estimate of $315.75 million. The business’s revenue for the quarter was up .1% on a year-over-year basis. Equities research analysts anticipate that LivaNova PLC will post $3.25 EPS for the current year.
In other news, Director Daniel Jeffrey Moore sold 1,000 shares of the company’s stock in a transaction that occurred on Friday, September 15th. The stock was sold at an average price of $68.55, for a total value of $68,550.00. Following the transaction, the director now owns 57,296 shares of the company’s stock, valued at $3,927,640.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Insiders sold 3,000 shares of company stock worth $190,860 in the last ninety days. 0.28% of the stock is owned by company insiders.
LivaNova PLC Company Profile
LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company’s segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products.
Receive News & Stock Ratings for LivaNova PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova PLC and related stocks with our FREE daily email newsletter.